nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—MTNR1A—forebrain—Parkinson's disease	0.0254	0.138	CbGeAlD
Agomelatine—HTR2C—telencephalic ventricle—Parkinson's disease	0.0238	0.13	CbGeAlD
Agomelatine—MTNR1B—head—Parkinson's disease	0.0184	0.1	CbGeAlD
Agomelatine—Melatonin—NQO2—Parkinson's disease	0.017	0.57	CrCbGaD
Agomelatine—MTNR1A—head—Parkinson's disease	0.0145	0.0791	CbGeAlD
Agomelatine—MTNR1A—nervous system—Parkinson's disease	0.0138	0.075	CbGeAlD
Agomelatine—MTNR1A—central nervous system—Parkinson's disease	0.0133	0.0722	CbGeAlD
Agomelatine—MTNR1A—brain—Parkinson's disease	0.0105	0.0573	CbGeAlD
Agomelatine—HTR2C—brainstem—Parkinson's disease	0.00644	0.0351	CbGeAlD
Agomelatine—HTR2C—forebrain—Parkinson's disease	0.00621	0.0338	CbGeAlD
Agomelatine—Midodrine—CYP2D6—Parkinson's disease	0.00596	0.2	CrCbGaD
Agomelatine—HTR2B—forebrain—Parkinson's disease	0.00584	0.0318	CbGeAlD
Agomelatine—Encainide—CYP2D6—Parkinson's disease	0.00531	0.178	CrCbGaD
Agomelatine—HTR2B—cardiovascular system—Parkinson's disease	0.00493	0.0269	CbGeAlD
Agomelatine—HTR2C—medulla oblongata—Parkinson's disease	0.00449	0.0244	CbGeAlD
Agomelatine—HTR2C—midbrain—Parkinson's disease	0.0041	0.0223	CbGeAlD
Agomelatine—HTR2C—spinal cord—Parkinson's disease	0.004	0.0218	CbGeAlD
Agomelatine—HTR2C—head—Parkinson's disease	0.00356	0.0194	CbGeAlD
Agomelatine—HTR2C—nervous system—Parkinson's disease	0.00337	0.0184	CbGeAlD
Agomelatine—HTR2B—head—Parkinson's disease	0.00334	0.0182	CbGeAlD
Agomelatine—HTR2C—central nervous system—Parkinson's disease	0.00325	0.0177	CbGeAlD
Agomelatine—CYP2C9—cardiovascular system—Parkinson's disease	0.0032	0.0174	CbGeAlD
Agomelatine—HTR2B—nervous system—Parkinson's disease	0.00317	0.0173	CbGeAlD
Agomelatine—HTR2B—central nervous system—Parkinson's disease	0.00305	0.0166	CbGeAlD
Agomelatine—HTR2C—brain—Parkinson's disease	0.00258	0.014	CbGeAlD
Agomelatine—HTR2B—brain—Parkinson's disease	0.00242	0.0132	CbGeAlD
Agomelatine—Indomethacin—ABCB1—Parkinson's disease	0.00155	0.0521	CrCbGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR7—Parkinson's disease	0.000477	0.000607	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR7—Parkinson's disease	0.000477	0.000607	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD2—Parkinson's disease	0.000477	0.000607	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD2—Parkinson's disease	0.000477	0.000607	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD1—Parkinson's disease	0.000468	0.000595	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000467	0.000594	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GRK5—Parkinson's disease	0.000466	0.000593	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000463	0.000589	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—GRM4—Parkinson's disease	0.000461	0.000586	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—GRM5—Parkinson's disease	0.00046	0.000585	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000457	0.000581	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD3—Parkinson's disease	0.000453	0.000576	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000452	0.000575	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DGKQ—Parkinson's disease	0.000451	0.000573	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GPR37—Parkinson's disease	0.000451	0.000573	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—PDYN—Parkinson's disease	0.000449	0.000571	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00044	0.00056	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—VPS35—Parkinson's disease	0.000439	0.000558	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PENK—Parkinson's disease	0.000437	0.000555	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000433	0.00055	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000431	0.000548	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000427	0.000543	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000424	0.000538	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GRM4—Parkinson's disease	0.000418	0.000532	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—GRM5—Parkinson's disease	0.000418	0.000531	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000412	0.000524	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HTR7—Parkinson's disease	0.00041	0.000521	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD2—Parkinson's disease	0.00041	0.000521	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—EDN1—Parkinson's disease	0.000407	0.000517	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IGF2—Parkinson's disease	0.0004	0.000508	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IGF2—Parkinson's disease	0.0004	0.000508	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—PDYN—Parkinson's disease	0.000399	0.000508	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PENK—Parkinson's disease	0.000396	0.000504	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000396	0.000503	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000391	0.000497	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00039	0.000496	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IGF1R—Parkinson's disease	0.000387	0.000492	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IGF1R—Parkinson's disease	0.000387	0.000492	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000384	0.000488	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EDN1—Parkinson's disease	0.000382	0.000486	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EDN1—Parkinson's disease	0.000382	0.000486	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000382	0.000486	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000381	0.000484	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000379	0.000481	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000377	0.000479	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000377	0.000479	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—GRM5—Parkinson's disease	0.000371	0.000472	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DGKQ—Parkinson's disease	0.000363	0.000462	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GPR37—Parkinson's disease	0.000363	0.000462	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—PDYN—Parkinson's disease	0.000363	0.000461	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000362	0.00046	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—RIT2—Parkinson's disease	0.00036	0.000458	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—HTR2A—Parkinson's disease	0.000356	0.000452	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000355	0.000452	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NGF—Parkinson's disease	0.000351	0.000446	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NGF—Parkinson's disease	0.000351	0.000446	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000351	0.000446	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000346	0.00044	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GRK5—Parkinson's disease	0.000341	0.000434	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00034	0.000432	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GRM5—Parkinson's disease	0.000337	0.000429	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TAC1—Parkinson's disease	0.000334	0.000425	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR2A—Parkinson's disease	0.000334	0.000425	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR2A—Parkinson's disease	0.000334	0.000425	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000332	0.000423	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—EDN1—Parkinson's disease	0.000328	0.000417	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.000328	0.000417	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000328	0.000417	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000328	0.000417	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD1—Parkinson's disease	0.000328	0.000417	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.000326	0.000415	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.000326	0.000414	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.000323	0.000411	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000322	0.000409	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD3—Parkinson's disease	0.000318	0.000404	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000316	0.000401	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—APOE—Parkinson's disease	0.000311	0.000395	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—APOE—Parkinson's disease	0.000311	0.000395	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR1A—Parkinson's disease	0.000308	0.000392	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GRM4—Parkinson's disease	0.000306	0.000389	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TAC1—Parkinson's disease	0.000304	0.000386	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.0003	0.000381	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD1—Parkinson's disease	0.000298	0.000379	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000297	0.000377	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000296	0.000376	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—RIT2—Parkinson's disease	0.000291	0.000369	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PENK—Parkinson's disease	0.00029	0.000369	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAG—Parkinson's disease	0.00029	0.000369	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD3—Parkinson's disease	0.000288	0.000367	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD2—Parkinson's disease	0.000287	0.000365	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR7—Parkinson's disease	0.000287	0.000365	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HTR2A—Parkinson's disease	0.000287	0.000365	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000287	0.000364	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GRK5—Parkinson's disease	0.000275	0.00035	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000274	0.000348	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TAC1—Parkinson's disease	0.00027	0.000343	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000269	0.000342	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—PDYN—Parkinson's disease	0.000266	0.000338	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—INS—Parkinson's disease	0.000265	0.000337	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—INS—Parkinson's disease	0.000265	0.000337	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD1—Parkinson's disease	0.000265	0.000336	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000264	0.000336	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR7—Parkinson's disease	0.000261	0.000332	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD2—Parkinson's disease	0.000261	0.000332	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD3—Parkinson's disease	0.000256	0.000326	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GFAP—Parkinson's disease	0.00025	0.000317	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000249	0.000316	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000249	0.000316	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR1A—Parkinson's disease	0.000249	0.000316	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GRM4—Parkinson's disease	0.000247	0.000314	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GRM5—Parkinson's disease	0.000247	0.000314	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TAC1—Parkinson's disease	0.000245	0.000311	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD1—Parkinson's disease	0.00024	0.000305	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000239	0.000304	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PENK—Parkinson's disease	0.000234	0.000298	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAG—Parkinson's disease	0.000234	0.000298	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000234	0.000297	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000234	0.000297	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD3—Parkinson's disease	0.000233	0.000296	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR7—Parkinson's disease	0.000232	0.000295	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD2—Parkinson's disease	0.000232	0.000295	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—EDN1—Parkinson's disease	0.00023	0.000292	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000226	0.000287	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000222	0.000282	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000219	0.000278	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000217	0.000276	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGF20—Parkinson's disease	0.000216	0.000275	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—PDYN—Parkinson's disease	0.000214	0.000272	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000213	0.00027	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000213	0.00027	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000212	0.000269	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR7—Parkinson's disease	0.00021	0.000267	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD2—Parkinson's disease	0.00021	0.000267	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.00021	0.000267	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EDN1—Parkinson's disease	0.000209	0.000265	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GFAP—Parkinson's disease	0.000201	0.000256	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000201	0.000256	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—OMD—Parkinson's disease	0.0002	0.000254	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.0002	0.000254	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GRM5—Parkinson's disease	0.000199	0.000253	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CASP3—Parkinson's disease	0.000198	0.000251	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CASP3—Parkinson's disease	0.000198	0.000251	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6—Parkinson's disease	0.000196	0.00025	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6—Parkinson's disease	0.000196	0.00025	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—INSR—Parkinson's disease	0.000194	0.000246	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000191	0.000243	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.00019	0.000241	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000189	0.00024	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000189	0.00024	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000189	0.00024	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—EDN1—Parkinson's disease	0.000185	0.000236	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FGB—Parkinson's disease	0.000183	0.000233	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000183	0.000232	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR1A—Parkinson's disease	0.000182	0.000232	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MAPK8—Parkinson's disease	0.000182	0.000231	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MAPK8—Parkinson's disease	0.000182	0.000231	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.000181	0.00023	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TAC1—Parkinson's disease	0.000179	0.000228	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000177	0.000225	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD1—Parkinson's disease	0.000176	0.000224	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGF20—Parkinson's disease	0.000175	0.000222	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD3—Parkinson's disease	0.00017	0.000217	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADORA2A—Parkinson's disease	0.000169	0.000215	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EDN1—Parkinson's disease	0.000168	0.000214	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000163	0.000207	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000162	0.000206	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000161	0.000205	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000161	0.000205	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000161	0.000205	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000159	0.000202	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—INSR—Parkinson's disease	0.000156	0.000199	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR7—Parkinson's disease	0.000154	0.000196	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD2—Parkinson's disease	0.000154	0.000196	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FGB—Parkinson's disease	0.000148	0.000188	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	0.000147	0.000187	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	0.000147	0.000187	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	0.000145	0.000184	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	0.000142	0.00018	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000138	0.000176	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	0.000137	0.000175	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.000131	0.000166	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	0.000129	0.000164	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000129	0.000164	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	0.000128	0.000163	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	0.000125	0.000159	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	0.000124	0.000158	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	0.000124	0.000158	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	0.000123	0.000157	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—DDC—Parkinson's disease	0.000118	0.00015	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000118	0.00015	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000117	0.000148	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—Parkinson's disease	0.000116	0.000147	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—Parkinson's disease	0.000116	0.000147	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NGF—Parkinson's disease	0.000113	0.000144	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000112	0.000142	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000111	0.000141	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00011	0.00014	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	0.000108	0.000137	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	0.000104	0.000132	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	0.000101	0.000128	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000101	0.000128	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—APOE—Parkinson's disease	0.0001	0.000128	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MAOB—Parkinson's disease	9.96e-05	0.000127	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	9.95e-05	0.000127	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.48e-05	0.00012	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	9.14e-05	0.000116	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	8.71e-05	0.000111	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	8.66e-05	0.00011	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—INS—Parkinson's disease	8.57e-05	0.000109	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CTGF—Parkinson's disease	8.5e-05	0.000108	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	8.09e-05	0.000103	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	7.92e-05	0.000101	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—NQO1—Parkinson's disease	7.83e-05	9.96e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—TH—Parkinson's disease	7.72e-05	9.81e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CYCS—Parkinson's disease	7.41e-05	9.42e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	7.4e-05	9.41e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CTGF—Parkinson's disease	7.26e-05	9.24e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—INS—Parkinson's disease	6.91e-05	8.79e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	6.77e-05	8.61e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—NQO1—Parkinson's disease	6.69e-05	8.51e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—TH—Parkinson's disease	6.6e-05	8.39e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—COMT—Parkinson's disease	6.56e-05	8.34e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	6.53e-05	8.31e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MAOA—Parkinson's disease	6.52e-05	8.29e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	6.44e-05	8.19e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	6.38e-05	8.11e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	6.34e-05	8.06e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CYCS—Parkinson's disease	6.33e-05	8.05e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	6.18e-05	7.86e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	6e-05	7.63e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	5.86e-05	7.45e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GPX1—Parkinson's disease	5.75e-05	7.31e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—COMT—Parkinson's disease	5.61e-05	7.13e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	5.58e-05	7.1e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MAOA—Parkinson's disease	5.57e-05	7.08e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	5.51e-05	7e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	5.31e-05	6.74e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	5.28e-05	6.72e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	5.15e-05	6.54e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	5.13e-05	6.52e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	5.11e-05	6.5e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—APOE—Parkinson's disease	4.94e-05	6.28e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GPX1—Parkinson's disease	4.91e-05	6.25e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	4.73e-05	6.01e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	4.53e-05	5.76e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—APOE—Parkinson's disease	4.22e-05	5.37e-05	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—INS—Parkinson's disease	4.22e-05	5.36e-05	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—Parkinson's disease	3.74e-05	4.76e-05	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—INS—Parkinson's disease	3.61e-05	4.58e-05	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	3.02e-05	3.84e-05	CbGpPWpGaD
